Adolescents living with human immunodeficiency virus (HIV) (ALHIV) globally, report worse treatment outcomes compared to adults and children on antiretroviral therapy (ART). The photovoice study is part of a larger research project that aimed to improve treatment outcomes—adherence, retention in care and viral suppression—for ALHIV who were receiving ART at public health care facilities in the Cape Metropole in South Africa.